Simplifying Cell Line Development Workflows Using Integrated, High-throughput Screening Tools

Commercialization of a biologic is a lengthy and expensive process. Successful cell line development is heavily dependent upon balancing time and resources with acquiring high quality data for informed decisions. Each stage of the cell line development (CLD) workflow has challenges and there is a real need for advanced strategies and intelligent use of innovative solutions. This webinar focuses on early-stage cell line development with instrumentation that is tailored for high-throughput screening, enabling reliable identification of robust, scalable, and high-titer clones. The CellCelector, iQue®, Octet® and Ambr® 15 CC platforms are perfectly designed to seamlessly work together to streamline the early cell line development workflow, enabling data-driven decisions and reducing risk during later stages of biologic development. As well as having the right tools, experience in how to best integrate them into these workflows is just as invaluable. This webinar aims to educate the user on how integration can be achieved by highlighting the instruments strengths and capabilities and where they best fit into the cell line development workflow.